Genetic study in a family with dopa-responsive dystonia revealed a novel mutation in sepiapterin reductase gene

Abstract

Dopa-responsive dystonia due to sepiapterin reductase deficiency (OMIM#612716) is caused by recessive mutations in the gene encoding sepiapterin reductase (SPR), which plays an important role in the biosynthesis of tetrahydrobiopterin (BH4). One Jordanian patient to first cousin parents is reported in this study. The parents of the proband have recognized the symptoms of their daughter at six months old with motor developmental delay. The symptoms were progressed after-then to include speech delay, seizure, ataxia, oculomotor apraxia, dysarthia and choreoathetosis. Despite of these symptoms, the clinicians in Jordan were unable to diagnose the case. In August 2018, the proband (8 years old) was presented to the department of biotechnology and genetic engineering at Philadelphia University in Jordan for the purposes of performing whole exome sequencing (WES). Analysis of WES data has revealed novel homozygous frameshift variant in the gene SPR (NM_003124.4:c.40delG,p.Ala15Profs*100). The variant is heterozygous in the parents and in the healthy male siblings. Therefore, the studied case was diagnosed with sepiapterin reductase deficiency. Because this disease is likely to be treated recommendations were given to the family immediately to start treatments trials. The case in this study illustrates the difficulties of diagnosing sepiapterin reductase deficiency based on clinical symptoms only and thus renders the possibilities of early management. Also, this study reinforces the importance of running WES to undiagnosed neurodevelopmental cases.
 doi: https://doi.org/10.12669/pjms.35.6.1181
 How to cite this:Froukh T. Genetic study in a family with dopa-responsive dystonia revealed a novel mutation in sepiapterin reductase gene. Pak J Med Sci. 2019;35(6):1736-1739. doi: https://doi.org/10.12669/pjms.35.6.1181
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Nephrocalcinosis in genetically proved dopa-responsive dystonia due to sepiapterin reductase deficiency in a Libyan Girl

“…DRD comprises a genetically heterogeneous group of movement disorders with both autosomal dominant and recessive traits, [4,8] The phenotypic spectrum of SPR deficiency has not been completely elucidated due to the small number of affected people. In 2015, a total of fifty cases were reported all over the world.…”

Genetic basis of neurodevelopmental disorders in 103 Jordanian families

“…As an example, in Jordan only a limited number of families with children with NDDs underwent extensive molecular testing in a research context leaving the majority of patients without a firm diagnosis. [5][6][7][8][9][10][11][12][13] This study aims to establish whole exome sequencing (WES) as first-tier diagnostics in undiagnosed neurodevelopmental cases in Jordan.…”

Whole-exome sequencing in a cohort of Chinese patients with isolated cervical dystonia

“…Among reportedly dystonia-causing genes, TH and SPR had likely pathogenic variants ( Table 2 ), which were involved in dopa-responsive dystonia [ 19 , 20 ]. However, both patients (S33 and S39) who had respective variants in TH and SPR did not have fluctuating movement symptoms and had no response to levodopa (data not shown).…”